Success Metrics

Clinical Success Rate
87.5%

Based on 63 completed trials

Completion Rate
88%(63/72)
Active Trials
23(18%)
Results Posted
21%(13 trials)
Terminated
9(7%)

Phase Distribution

Ph phase_2
27
21%
Ph phase_3
3
2%
Ph not_applicable
73
58%
Ph phase_1
4
3%

Phase Distribution

4

Early Stage

27

Mid Stage

3

Late Stage

Phase Distribution107 total trials
Phase 1Safety & dosage
4(3.7%)
Phase 2Efficacy & side effects
27(25.2%)
Phase 3Large-scale testing
3(2.8%)
N/ANon-phased studies
73(68.2%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

84.0%

63 of 75 finished

Non-Completion Rate

16.0%

12 ended early

Currently Active

23

trials recruiting

Total Trials

126

all time

Status Distribution
Active(31)
Completed(63)
Terminated(12)
Other(20)

Detailed Status

Completed63
unknown20
Recruiting16
Terminated9
Active, not recruiting7
Not yet recruiting6

Development Timeline

Analytics

Development Status

Total Trials
126
Active
23
Success Rate
87.5%
Most Advanced
Phase 3

Trials by Phase

Phase 14 (3.7%)
Phase 227 (25.2%)
Phase 33 (2.8%)
N/A73 (68.2%)

Trials by Status

terminated97%
enrolling_by_invitation22%
unknown2016%
active_not_recruiting76%
recruiting1613%
withdrawn32%
not_yet_recruiting65%
completed6350%

Recent Activity

Clinical Trials (126)

Showing 20 of 126 trialsScroll for more
NCT07640802

Psychotherapy for Irritability in Youth: Comparing Active Treatment to Nonactive Psychoeducation Supportive Psychotherapy

Not Yet Recruiting
NCT07336238Phase 2

Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or Incurable Hematologic Malignancies

Active Not Recruiting
NCT07250893Not Applicable

Resolving Early Life Stress: Psychotherapy Outcomes and Neurobiology in Complex Depression

Recruiting
NCT06671158Not Applicable

Measurement-Based Care (MBC) Implementation, Effectiveness, and Mechanisms of Change

Active Not Recruiting
NCT07507370Not Applicable

CARED : A Novel Rapid Treatment Paradigm for Depression

Recruiting
NCT06827054Phase 2

Psilocybin With Psychotherapy for Improving Chronic Pain in Cancer Patients Requiring Opioids

Not Yet Recruiting
NCT05967052Phase 2

Investigation of Treating Chronic Fatigue Syndrome After COVID With Pharmacotherapy (Pregabalin) or Complex Rehabilitation

Terminated
NCT06622993Not Applicable

Effectiveness of the SKILLS Program in the Management of Psychiatric Disorders

Recruiting
NCT06538285Phase 2

Ketamine-Assisted Recovery for Methamphetamine Use Disorder & HIV

Active Not Recruiting
NCT06189027Phase 3

Epigenetics and MDMA-Assisted Psychotherapy for PTSD

Completed
NCT03376269Not Applicable

HBOT Effect on Chronic Pain Syndrome With a History of Psychological Trauma

Completed
NCT06004414Not Applicable

SilverCloud as a School-Based Intervention for Vulnerable Youth

Recruiting
NCT07200531Not Applicable

Does Psychotherapy Change the Gut Microbiome in Women of Child-bearing Age?

Recruiting
NCT06253403

Female Sexual Dysfunction and Anorexia Nervosa

Completed
NCT07432646

"Finding Solid Ground" in Inpatient Treatment for Dissociative Disorder Patients Followed by Transition to Outpatient Treatment Settings: A 1-year Follow-up Pilot Study

Completed
NCT06042751Not Applicable

Psychosomatic, Physical Activity or Both for Post-covid19 Syndrom

Active Not Recruiting
NCT04950608Phase 2

Pilot Study of Psilocybin-Assisted Therapy for Demoralization in Patients Receiving Hospice Care

Completed
NCT06206265Phase 2

Assessment of Psilocybin (TRP-8802) in Concert With Psychotherapy in Patients With Irritable Bowel Syndrome (IBS)

Active Not Recruiting
NCT05398484Phase 2

Psilocybin Therapy in Advanced Cancer

Recruiting
NCT07253935Not Applicable

Impact of Therapeutic Exercise Integrated With Psychotherapy and Education in Patients With Depression

Not Yet Recruiting

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
126